BiopharmaRX is an independent clinical research company dedicated to providing high quality clinical trials from preclinical to phase 3 studies.
With a network of research laboratories and clinics across the pacific rim countries, we are capable of design and conducting animal studies, phase 1 to phase 3 clinical trials
Learn more
Sponsors in Europe and North America are facing increased challenges in participant recruitment and retention, lengthy timeframes and relatively high costs.
With a network of testing sites in Asia-Pacific region, BiopharmaRx offers large patient population, accessibility to KOLs and medical facilities, government support for clinical trials, lower costs, high-quality standards and expedited regulatory environment.
Learn more
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international biopharmaceutical companies who can take advantage of a uniquely fast and pragmatic regulatory pathway for early phase clinical trials.
BiopharmaRx is able to provide gap analysis and critical assessment of client’s pre-/non-clinical data to ensure our client’s package is ready and suitable for submission
The simplicity and efficiency of the Australian and New Zealand Regulatory and Ethics (IRB) processes often means our clients can defer regulatory submissions in other regions by initiating their clinical programs in Australia and/or New Zealand and commencing subject treatment within a single review cycle of 6-8 weeks from submission.